Aveo Pharmaceuticals Inc. failed to win the backing of U.S. regulatory advisers for its lead product candidate, a kidney cancer drug, after the panelists questioned whether it was as effective as existing treatments.
Washington is poised to be one of the only major U.S. cities with a decline in apartment rents this year after a surge in construction outpaced job growth, leaving the nation’s capital with a glut of properties.
GlaxoSmithKline Plc and Theravance Inc.’s Breo Ellipta should be approved to treat a lung disorder that is the third-leading cause of death in the U.S., advisers to the Food and Drug Administration said.
GlaxoSmithKline Plc’s Avandia, the best-selling diabetes pill that was pulled off the market in Europe and tightly restricted in the U.S. because of its heart risks, will undergo another regulatory review.
Silver Spring Networks Inc., the maker of networking equipment for smart electricity grids, surged in its first day of trading after raising 21 percent more than planned in a U.S. initial public offering.
Silver Spring Networks Inc., the maker of networking equipment for smart electricity grids, seeks to raise about $67 million in its initial public offering, less than half the amount it initially sought, after waiting more than a year and a half to proceed with the sale.
Silver Spring Networks Inc., the maker of networking equipment for smart electricity grids, raised $81 million in its initial public offering after pricing an increased number of shares at the midpoint of the range.